Brainstorm Cell Therapeutics (BCLI) Return on Equity [ROE] (2011 - 2022)
Brainstorm Cell Therapeutics (BCLI) reported Return on Equity [ROE] of -304.06% for FY2022, down 214.51 percentage points from -89.55% in FY2021.
Powered by 
Analysis
Brainstorm Cell Therapeutics (BCLI) Return on Equity [ROE] (2011 - 2022) Analysis & Trends
Dating back to FY2011, Brainstorm Cell Therapeutics' Return on Equity [ROE] record includes 11 years.
- Return on Equity [ROE] has a five-year change of -240.71 percentage points (FY2017 to FY2022).
- The FY2022 figure ranks as the lowest annual Return on Equity [ROE] since FY2011.
- According to Business Quant data, Return on Equity [ROE] came in at -89.55% in FY2021 (+183.11 pp), -272.66% in FY2020 and -258.13% in FY2018 (-194.78 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Brainstorm Cell Therapeutics | 10.92 Mn | 10.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | -577.21% |
| Jun 30, 2022 | -225.11% |
| Mar 31, 2022 | -137.57% |
| Dec 31, 2021 | -111.70% |
| Sep 30, 2021 | -110.16% |
| Jun 30, 2021 | -88.89% |
| Mar 31, 2021 | -85.47% |
| Dec 31, 2020 | -103.55% |
| Sep 30, 2020 | -154.68% |
| Jun 30, 2020 | -306.21% |
| Mar 31, 2019 | -624.37% |
| Dec 31, 2018 | -186.05% |
| Sep 30, 2018 | -72.55% |
| Jun 30, 2018 | -89.97% |
| Mar 31, 2018 | -112.52% |
| Dec 31, 2017 | -89.43% |
| Sep 30, 2017 | -94.16% |
| Jun 30, 2017 | -65.83% |
| Mar 31, 2017 | -55.73% |
| Dec 31, 2016 | -49.55% |
API Access
Brainstorm Cell Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BCLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "BCLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BCLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();